Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2003
11/06/2003WO2003014388A3 Method and nucleic acids for the analysis of colon cancer
11/06/2003WO2003014379A3 Improved method and composition for determining resistance to an acetohydroxyacid synthase inhibitor
11/06/2003WO2003012124A3 Methods for immobilizing molecules to a solid phase and uses thereof
11/06/2003WO2003012069A3 Compositions and methods for generating chimeric heteromultimers
11/06/2003WO2003005972A3 Method for identifying tolerance in graft recipients
11/06/2003WO2003005628A3 Generating, viewing, interpreting, and utilizing a quantitative database of metabolites
11/06/2003WO2003003906A3 Diagnostic and screening methods for bladder cancer
11/06/2003WO2003002604A3 G protein coupled receptors and dna sequences thereof
11/06/2003WO2003001203A3 Inverse chromatography methods and apparatus for evaluation of interactions between modifying agents and receptors
11/06/2003WO2002101393A3 Method for identifying interaction between proteins and dna fragments of a genome
11/06/2003WO2002098916A3 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
11/06/2003WO2002097442A3 Device for presenting polypeptides, able to be used as a chip for miniaturised detection of molecules
11/06/2003WO2002097440A3 Method for determining peptides or proteins, mass spectrometry for metals and determination of conductivity capacity
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002085926A3 Method for producing stable, regeneratable antibody arrays
11/06/2003WO2002084296A3 Method for selecting immunological binding molecules
11/06/2003WO2002083854A9 Antibodies to vla-1
11/06/2003WO2002083711A3 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
11/06/2003WO2002082043A3 Transgenic zebrafish models for neurodegenerative diseases
11/06/2003WO2002081741A3 Use of products of genes of the 2'-5' oligoadenylate synthetase family (oas) for screening antiviral agents and for detecting responsiveness to flaviviridae infection
11/06/2003WO2002081740A8 Supported double-layer structure for displaying a nucleic acid associated with a protein
11/06/2003WO2002081641A3 Gene scc-112 and diagnostic and therapeutic uses thereof
11/06/2003WO2002080960A3 Treatment of neuropathologies associated with expression of tnf-alpha
11/06/2003WO2002079507A3 Method for specifically detecting, isolating and characterizing cells from body samples by transfecting nucleic acid constructs
11/06/2003WO2002077605A3 Reentrant cavity bioassay for detecting molecular or cellular events
11/06/2003WO2002077200A3 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors
11/06/2003WO2002076482B1 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
11/06/2003WO2002075317A3 Screening for drugs against disorders associated with schizophrenia
11/06/2003WO2002073207A3 Isolated ductal fluid sample
11/06/2003WO2002072631A3 Mhc molecule constructs and their usesfor diagnosis and therapy
11/06/2003WO2002072600A3 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections
11/06/2003WO2002070657A8 93870, a human g-protein coupled receptor and uses therefor
11/06/2003WO2002066984A8 Arrays for determining binding of biomolecules
11/06/2003WO2002066649A8 ANTI-INTERFERON-α ANTIBODIES
11/06/2003WO2002063287A3 Method and system to remotely monitor a carbon adsorption process
11/06/2003WO2002062945A3 Compositions and methods relating to lung specific genes and proteins
11/06/2003WO2002061105A3 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
11/06/2003WO2002059558A8 Means and methods for treatment evaluation
11/06/2003WO2002059371A3 Genome-wide location and function of dna binding proteins
11/06/2003WO2002059352A3 Methods and means for detecting enzymatic cleavage and linkage reactions
11/06/2003WO2002059348A3 Methods for determining the genetic affinity of microorganisms and viruses
11/06/2003WO2002059312A3 Cell adhesion proteins
11/06/2003WO2002057792A3 Affinity selection-based screening of hydrophobic proteins
11/06/2003WO2002057489A3 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression
11/06/2003WO2002056013A3 Oxazolidinone photoaffinity probes, uses and compounds
11/06/2003WO2002053742A3 Proteins and nucleic acids encoding same
11/06/2003WO2002050260A3 Process for the production and purification of secreted proteins ans the production of arrays of proteins
11/06/2003WO2002048701A8 Nanosensors
11/06/2003WO2002046722A9 Method for diagnosing pathology in biological samples
11/06/2003WO2002046475A3 Method of detecting and treating tuberous sclerosis complex associated disorders
11/06/2003WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
11/06/2003WO2002027031A3 Methods and reagents for live-cell gene expression quantification
11/06/2003WO2002026785A3 Epitopes of virus hepatitis c specifically cd4+ t lymphocytes
11/06/2003WO2002018643A9 Nanoparticles having oligonucleotides attached thereto and uses therefor
11/06/2003WO2002010746A3 Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal
11/06/2003WO2002006828A8 Hemoglobin sensor
11/06/2003WO2002006788A8 Electrochemical method for measuring chemical reaction rates
11/06/2003WO2002004952A3 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
11/06/2003WO2001080633A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/06/2003WO2000067634A3 Airway-based cardiac output monitor and methods for using same
11/06/2003WO2000026247A8 Ikaros isoforms and mutants
11/06/2003WO2000023569A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
11/06/2003US20030208454 Method and system for populating a database for further medical characterization
11/06/2003US20030208322 Apparatus, method, and computer program product for plotting proteomic and genomic data
11/06/2003US20030208140 Analyte concentration determination devices and methods of using the same
11/06/2003US20030208133 Breath ketone analyzer
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030208055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030208053 Methods and compositions utilizing rad51
11/06/2003US20030208052 Method of concentrating proteins from serum
11/06/2003US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
11/06/2003US20030207978 Drug delivery; improved refractive index, transparency to light, reflection, permeability, coercivity, magnetic hystereisis, breakdown voltage, biocompatability, and wear resistance
11/06/2003US20030207977 Drug delivery; improved refractive index, transparency to light, reflection, permeability, coercivity, magnetic hysteresis, breakdown voltage, biocompatability, and wear resistance
11/06/2003US20030207976 Thermal properties modified by powder size; whisker type fillers; drug delivery
11/06/2003US20030207975 Improved wear resistance/biocompatibility
11/06/2003US20030207936 Comprises fatty ester modified-polyoxyethylene glycol solubilizers
11/06/2003US20030207885 Nitrogen compounds such as 6-chloro-3-ethyl-2-(2-thiazol-2-yl -imidazol-1-ylmethyl)-imidazo(1,2-b)pyridazine used for prophylaxis of nervous system disorders
11/06/2003US20030207835 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
11/06/2003US20030207833 Composition comprising a minicell, wherein said minicell displays a membrane protein, wherein said membrane protein is selected from the group consisting of a eukaryotic membrane protein, an archeabacterial membrane protein and an
11/06/2003US20030207828 DNA whose expression level fluctuates in leukocytes of IgA nephropathy patients in comparison with leukocytes of healthy persons, a process for isolating the DNA, a novel protein encoded by the DNA, an antibody recognizing the protein,
11/06/2003US20030207793 Secreted alpha-helical protein - 32
11/06/2003US20030207792 Screening for effective agents for the treatment of cancer which method comprises testing a putative agent that is likely to disrupt a critical normal gene product present in said cancer for its cytotoxic and/or growth inhibitory effect
11/06/2003US20030207791 Modulating the strong-self-association of chimeric transcription factors to form high molecular weight (HMW) complexes. The invention further provides compounds comprising the oligomerization domains of oligomeric substances and a
11/06/2003US20030207469 Via immunoassay; low cross-reactivity with ephedrine and other compounds; antibody produced by a methylene dioxyphenyl derivative of agiven structure
11/06/2003US20030207467 Used to assay simultaneously the presence, amount, and/or function of proteins present in a protein sample/chip, or to assay the presence, relative specificity, and binding affinity of each probe in a mixture of probes for each of the proteins
11/06/2003US20030207466 Analytical test device and method of use
11/06/2003US20030207465 Assays
11/06/2003US20030207461 For coding polymeric microbeads or particles
11/06/2003US20030207459 Semen detection system and method
11/06/2003US20030207454 For use in home, physician's office, clinic or hospital
11/06/2003US20030207449 Human ovarian mesothelial cells and methods of isolation and uses thereof
11/06/2003US20030207447 Used to distinguish between arterial endothelial cells (arteries) and venous endothelial cells (veins)
11/06/2003US20030207446 Infectious papillomavirus pseudoviral particles
11/06/2003US20030207442 Method for detecting the presence of an analyte in a sample
11/06/2003US20030207441 Devices and methods for analyte concentration determination
11/06/2003US20030207434 Phosphodiesterases
11/06/2003US20030207431 Properties of mycophenolic acid inhibition of IMPDH (inosine-5'-monophosphate dehydrogenase) that allow the development of the immunoassay; drug conjugates with an uncompetitive inhibitor of IMPDH, mycophenolic acid
11/06/2003US20030207429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 ... 3937